Theranos Closes Blood-Testing Labs to Focus on New ProductBy
Holmes will stay on as CEO with ‘new executive team’
Blood testing company will focus on next ‘miniLab’ product
Embattled startup Theranos Inc. will close its blood-testing labs and fire about 340 workers, shifting its focus to an experimental technology following months of run-ins with regulators and questions about whether its existing products work.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.